Bharat Immunologicals & Biologicals Corporation fundamental analysis

BIBCL

20.48

0.17 (0.84%)
Last updated on 10 Nov, 2025 | 13:23 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Bharat Immunologicals & Biologicals Corporation Fundamentals

P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

36.99

Sector P/B

3.63

Sec. Div. Yield

0.56

  • Bharat Immunologicals & Biologicals Corporation Fundamentals is currently trading with a P/E Ratio of 0, compared to the sector average of 36.99. Its P/B Ratio stands at 0, while the sector’s is 3.63. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.56%.

Bharat Immunologicals & Biologicals Corporation Score Card

  • Price

    Attractive

  • Growth

    Average

  • Quality

    Poor

  • Management

    Poor

  • On its scorecard, Bharat Immunologicals & Biologicals Corporation reflects: Price – Attractive, Growth – Average, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.